Expérimentation préclinique et recherche clinique
Radiobiology of alpha emitters : development of an in vitro tumor model of targeted alpha-therapy
Jacquet C, Oger R, Gouard S, Eychenne R, Maingueneau C, Ligeour M, Guérard F, Chérel M, Gaschet J, Guilloux Y, Allard M
15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022Locoregional Astatine-211 Radioimmunotherapy Targeting Syndecan-1 in a Syngeneic Glioblastoma Mouse Model
Roncali L, Roy C, Marionneau-Lambot S, Gouard S, Eychenne R, Avril S, Guérard F, Hindré F, Chérel M, Garcion E
15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022Study of radiolabeled hepatotropic peptide derivatives for the diagnosis and treatment of hepatocellular carcinoma
Nahas H, Brossard C, Vene E, Gouard S, Chérel M, Bourgeois M, Loyer P, Lepareur N, Cammas-Marion S
15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022Novel Positron Emission Tomography with Opaque Liquid Scintillator Detection Technology
Hourlier A, Bongrand M, Bourgeois C, Brasse D, Breton D, Briere M, Cabrera A, Chaumat V, Dahmane A, Gazzini R, Giovagnoli D, Haddad F, Hull G, Lanièce P, Lefevre F, Loaiza P, Maalmi J, Mellak Y, merlin T, Mastrippolito R, Marquet C, Ménard L, navas-Nicolas D, Pillot P, Simard L, Stocco D, Verdier MA, Visvikis D, Yermia F
15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, 5-8 octobre 2022La ligne de faisceau d’Arronax pour les études précliniques
Koumeir C
AG du GDR MI2B, Orsay, France, 13-15 juin 2022